Vivos Therapeutics, Inc.
VVOS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,136 | -$13,583 | -$23,845 | -$20,288 |
| Dep. & Amort. | $581 | $621 | $669 | $733 |
| Deferred Tax | $0 | $0 | $0 | $1,143 |
| Stock-Based Comp. | $762 | $924 | $2,396 | $2,658 |
| Change in WC | -$2,940 | $2,864 | $1,711 | $28 |
| Other Non-Cash | $42 | -$2,772 | -$518 | -$9 |
| Operating Cash Flow | -$12,691 | -$11,946 | -$19,587 | -$15,735 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$568 | -$853 | -$924 | -$2,396 |
| Net Acquisitions | $0 | $0 | $0 | -$225 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $13 |
| Investing Cash Flow | -$568 | -$853 | -$924 | -$2,608 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$25 |
| Stock Issued | $7,796 | $10,923 | $0 | $25,692 |
| Stock Repurch. | $0 | $0 | $0 | -$1,500 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $10,080 | $0 | $0 | -$3,738 |
| Financing Cash Flow | $17,876 | $10,923 | $0 | $24,167 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4,617 | -$1,876 | -$20,511 | $5,824 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,643 | $3,519 | $24,030 | $18,206 |
| End Cash | $6,260 | $1,643 | $3,519 | $24,030 |
| Free Cash Flow | -$13,259 | -$12,749 | -$20,511 | -$18,131 |